Aerovate Therapeutics
AVTE
#5850
Rank
$0.59 B
Marketcap
$20.57
Share price
-6.12%
Change (1 day)
7.30%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total debt

Total debt on the balance sheet as of December 2023 : $0.67 M

According to Aerovate Therapeutics's latest financial reports the company's total debt is $0.67 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Aerovate Therapeutics - Total debt on balance sheet (from 2020 to 2023)

Total debt by year

Year Total debt Change
2022-12-31$1.09 M89.9%
2021-12-31$0.57 M
2020-12-31$N/A-100%
2019-12-31$2.5 M